Stock AVO ADVANCED ONCOTHERAPY PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials Advanced Oncotherapy plc

Equities

AVO

GB00BD6SX109

Advanced Medical Equipment & Technology

Market Closed - London S.E.
Other stock markets
 02:30:00 2023-06-30 am EDT 		5-day change 1st Jan Change
1.925 GBX -.--% Intraday chart for Advanced Oncotherapy plc +10.00% +10.00%
Apr. 02 Sareum ups retail offer; SThree nabs former ITV exec AN
Feb. 29 EARNINGS AND TRADING: Frontier IP sells last of Exscientia holding AN

Valuation

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Capitalization 1 54.73 46.54 66.98 97.54 120 171.6
Enterprise Value (EV) 1 53.83 55.73 68.97 140.8 168.4 220.7
P/E ratio -4.44 x -3.28 x -2.81 x -4.07 x -4.11 x -4.93 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA -4.22 x -3.94 x -3.22 x -7.07 x -8.74 x -9.73 x
EV / FCF -2.93 x -3.99 x -3.01 x -4.86 x -7.47 x -7.04 x
FCF Yield -34.1% -25% -33.2% -20.6% -13.4% -14.2%
Price to Book 1.61 x 1.62 x 1.97 x 2.28 x 2.72 x 2.8 x
Nbr of stocks (in thousands) 72,492 80,935 169,566 243,843 333,440 451,612
Reference price 2 0.7550 0.5750 0.3950 0.4000 0.3600 0.3800
Announcement Date 6/26/17 6/28/18 6/28/19 6/29/20 6/30/21 6/30/22
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net sales - - - - - -
EBITDA 1 -12.74 -14.13 -21.39 -19.93 -19.27 -22.69
EBIT 1 -13.09 -14.49 -21.8 -20.66 -20.27 -23.74
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -13.18 -16.49 -21.87 -21.88 -25.3 -29.49
Net income 1 -10.35 -13.66 -21.15 -20.79 -25.3 -29.49
Net margin - - - - - -
EPS 2 -0.1702 -0.1755 -0.1405 -0.0983 -0.0875 -0.0771
Free Cash Flow 1 -18.36 -13.95 -22.91 -28.96 -22.55 -31.36
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 6/26/17 6/28/18 6/28/19 6/29/20 6/30/21 6/30/22
1GBP in Million2GBP
Estimates

Balance Sheet Analysis

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net Debt 1 - 9.19 1.99 43.3 48.3 49.1
Net Cash position 1 0.91 - - - - -
Leverage (Debt/EBITDA) - -0.6506 x -0.0929 x -2.171 x -2.507 x -2.164 x
Free Cash Flow 1 -18.4 -14 -22.9 -29 -22.6 -31.4
ROE (net income / shareholders' equity) -33.8% -43.6% -67.4% -54.1% -58.1% -55.9%
ROA (Net income/ Total Assets) -23.9% -21.8% -26% -15.2% -10.9% -11.3%
Assets 1 43.27 62.64 81.38 137.1 232.8 262
Book Value Per Share 2 0.4700 0.3500 0.2000 0.1800 0.1300 0.1400
Cash Flow per Share 2 0.0200 0 0.0100 0.0100 0.0100 0.0100
Capex 1 0.77 0.12 3.29 2.66 1.66 2.22
Capex / Sales - - - - - -
Announcement Date 6/26/17 6/28/18 6/28/19 6/29/20 6/30/21 6/30/22
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
ADVANCED ONCOTHERAPY PLC Stock Advanced Oncotherapy plc
+10.00% 11.83M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.59% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.26% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.57% 108B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.65% 63.06B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.35% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.93% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.54% 39.35B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. AVO Stock
  4. Financials Advanced Oncotherapy plc